06:33 AM EST, 01/22/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) reported fiscal Q4 adjusted earnings Wednesday of $2.04 per diluted share, down from $2.29 a year earlier.

Analysts' estimates weren't readily available for comparison.

Sales for the quarter ended Dec. 29 were $22.52 billion, compared with $21.40 billion a year earlier.

Analysts surveyed by FactSet expected $22.43 billion.

The company said it expects full-year 2025 adjusted EPS in the range of $10.50 to $10.70. Two analysts polled by FactSet expect $10.85.

Sales for the year are expected to be in the range of $89.2 billion to $90 billion. Analysts polled by FactSet expect $90.98 billion.

Johnson & Johnson ( JNJ ) shares were up more than 1% in recent Wednesday premarket activity.

Price: 150.73, Change: +2.58, Percent Change: +1.74